SEC INSIDER TRANSACTIONS

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

CRL · CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 3 filings · fetched 2026-11-13T17:01:24Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

2sale rows on this page

7matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-06Filed 2026-11-09	Knell Michael GunnarOfficer · SVP, Finance and CAO Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units. Exhibit 24 - Power of Attorney References: F1	F WithholdingCommon Stock · Non-derivative	649D	313.02	Direct	Form 4 ↗0001100682-26-000159
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	24,042D	0	Direct	Form 4 ↗0001100682-26-000153
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References: F1	S Sale (market/private)Common Stock · Non-derivative	24,042D	350	Direct	Form 4 ↗0001100682-26-000153
2026-10-22Filed 2026-10-26	FOSTER JAMES CDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 6, 2026. Exhibit 24 - Power of Attorney References:	M Exercise / conversionCommon Stock · Non-derivative	24,042A	244.41	Direct	Form 4 ↗0001100682-26-000153
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionStock Options (Right to Buy) · Derivative	2,156D	0	Direct	Form 4 ↗0001100682-26-000151
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References: F1	S Sale (market/private)Common Stock · Non-derivative	2,156D	344.41	Direct	Form 4 ↗0001100682-26-000151
2026-10-21Filed 2026-10-23	Parisotto Shannon MOfficer · CEVP, Disc & Safety Assessment Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. References:	M Exercise / conversionCommon Stock · Non-derivative	2,156A	244.41	Direct	Form 4 ↗0001100682-26-000151

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.